FindTrial
Sign In

A study to evaluate the effect of a combination Giloy Gomutra Capsules, Asthi Churna and Kamdhenu Asava in COVID-19

A Clinical Evaluation of the combination Giloy Gaumutra Capsules, Asthi Churna and Kamdhenu Asava in the Management of the Pandemic- Covid-19.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025996
Enrollment
200
Registered
2020-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: A Clinical Study on the efficacy of the combination Giloy Gaumutra Capsules, Asthi Churna and Kamdhenu Aasava in the Management of the Pandemic- Covid-19- An Open labeled Randomized Cli

Sponsors

Bansi Gir Gaushala
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age: >18 years Patient having Covid-19 positive and with signs and symptoms of Covid-19.

Exclusion criteria

Exclusion criteria: Age: 60 years. Pregnant women and lactating mother Severe cases of Covid-19 like associated Pneumonia, COPD, and other severe associated diseases. Patient on ventilator. Uncontrolled Diabetes Mellitus & Hypertension Any other serious systemic illness like AIDS, Malignancy etc. Patients who are not willing to be included in the study

Design outcomes

Primary

MeasureTime frame
Symptoms of the Covid-19 patients will be evaluated for its recovery in each follow-up. Results will be seen as add-on treatment after comparing both the groups.Timepoint: On 7th and 15th days of the treatment—

Countries

India

Contacts

Public ContactDr Dineshchandra Pandya

Neuropanch Ayurveda Hospital and Research Organization

urvipandya18@gmail.com09638300839

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026